Sign In
Buy ABBV
$217.07
+1.64 (+0.761%)
At Close: Jun 03, 2026
AbbVie to Host Full-Year and Fourth-Quarter 2025 Earnings Conference Call
08:00am, Wednesday, 07'th Jan 2026
NORTH CHICAGO, Ill., Jan. 7, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its full-year and fourth-quarter 2025 financial results on Wednesday, February 4, 2026, before the market opens.
AbbVie Inc. $ABBV Shares Acquired by Cerity Partners LLC
05:32am, Wednesday, 07'th Jan 2026
Cerity Partners LLC boosted its position in shares of AbbVie Inc. (NYSE: ABBV) by 0.5% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Com
What Can Trigger A Breakout In Abbvie Stock?
11:43am, Tuesday, 06'th Jan 2026
AbbVie stock (NYSE:ABBV) has exhibited considerable rally potential, having once achieved over a 50% increase in less than two months in 2020. Furthermore, the stock has undergone seven rallies surpas
AbbVie (ABBV) Stock Falls Amid Market Uptick: What Investors Need to Know
06:45pm, Monday, 05'th Jan 2026
The latest trading day saw AbbVie (ABBV) settling at $220.18, representing a -3.98% change from its previous close.
AbbVie to Present at the 44th Annual J.P. Morgan Healthcare Conference
08:00am, Monday, 05'th Jan 2026
NORTH CHICAGO, Ill., Jan. 5, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) will present at the 44th Annual J.P.
Railway Pension Investments Ltd Raises Holdings in AbbVie Inc. $ABBV
07:21am, Monday, 05'th Jan 2026
Railway Pension Investments Ltd raised its stake in shares of AbbVie Inc. (NYSE: ABBV) by 33.0% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commi
Commonwealth Equity Services LLC Cuts Holdings in AbbVie Inc. $ABBV
05:10am, Monday, 05'th Jan 2026
Commonwealth Equity Services LLC lessened its position in shares of AbbVie Inc. (NYSE: ABBV) by 6.2% in the third quarter, according to the company in its most recent Form 13F filing with the Securiti
AbbVie Inc. $ABBV Holdings Raised by CWA Asset Management Group LLC
04:26am, Monday, 05'th Jan 2026
CWA Asset Management Group LLC grew its stake in shares of AbbVie Inc. (NYSE: ABBV) by 39.4% during the undefined quarter, according to the company in its most recent filing with the Securities and Ex
26 Top Dividend Stocks to Buy and Hold in 2026
03:45am, Monday, 05'th Jan 2026
Another year, another long list of great dividend stocks.
AbbVie: Rocky Near-Term, Positive Long-Term
09:04am, Sunday, 04'th Jan 2026
AbbVie outperformed the healthcare sector in 2025, but it remains to be seen whether the stock can repeat its performance in 2026. Last year, the stock was supported by relief for the pharmaceutical s
AbbVie Inc. $ABBV Holdings Lifted by Capital Advisors Inc. OK
04:18am, Sunday, 04'th Jan 2026
Capital Advisors Inc. OK increased its holdings in AbbVie Inc. (NYSE: ABBV) by 10.0% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange C
My Most Important Warning To Dividend Investors For 2026
07:30am, Saturday, 03'rd Jan 2026
The U.S. government is increasingly funding deficits with short-term debt, making interest expenses highly sensitive to Fed policy. A declining average maturity in the sovereign bond index tightens th
Buying This Healthcare Stock Could Make You a Millionaire Retiree
06:08am, Saturday, 03'rd Jan 2026
AbbVie has a solid business capable of performing well even in bad times. The company has proven that it can navigate challenges thanks to its innovative engine.
Bell Bank Sells 10,943 Shares of AbbVie Inc. $ABBV
05:04am, Saturday, 03'rd Jan 2026
Bell Bank lessened its position in shares of AbbVie Inc. (NYSE: ABBV) by 15.4% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission.
Here's How AbbVie's Neuroscience Portfolio Is Aiding Top-line Growth
08:46am, Friday, 02'nd Jan 2026
ABBV's neuroscience franchise now drives more than 17% of revenues, with strong Botox, Vraylar and migraine drug sales fueling double-digit growth.
